Junshi Biosciences Announces Acceptance of a Supplemental NDA in China for Toripalimab in Advanced Nasopharyngeal Carcinoma
April 30, 2020 10:56 ET
|
Junshi Biosciences
SHANGHAI, China, April 30, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and...
Junshi Biosciences Announces Approval of Proposed A-Share Listing by the Listing Committee for the Shanghai Stock Exchange (SSE) STAR Market
March 30, 2020 21:29 ET
|
Junshi Biosciences
SHANGHAI, China, March 30, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and...
Junshi Biosciences Announces Full-Year 2019 Financial Results and Business Updates
March 30, 2020 12:43 ET
|
Junshi Biosciences
SHANGHAI, March 30, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of...
Junshi Biosciences Receives Orphan Drug Designation from the U.S. FDA for Toripalimab in Combination with Pfizer’s Axitinib for the Treatment of Mucosal Melanoma
March 30, 2020 12:30 ET
|
Junshi Biosciences
SHANGHAI, China, March 30, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877) today announced that the U.S. Food and Drug Administration (FDA) has recently granted Orphan Drug Designation...
Junshi Biosciences Announces Co-Development Agreement with IMCAS to Advance Neutralizing Antibodies as Potential Novel Treatment for COVID-19
March 20, 2020 12:15 ET
|
Junshi Biosciences
SHANGHAI, China, March 20, 2020 (GLOBE NEWSWIRE) -- Junshi Biosciences (HKEX: 1877) announced that it has recently signed a collaboration agreement with the Institute of Microbiology of the Chinese...
Junshi Biosciences Reports Key 2019 Financial Results
March 02, 2020 14:19 ET
|
Junshi Biosciences
SHANGHAI, China, March 02, 2020 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd. ("the Company," HKEX: 1877), an innovation-driven biopharmaceutical company dedicated to the discovery and...